VILS
VILS is a Belgian design-build engineering firm that designs and delivers GMP-compliant manufacturing facilities for life science companies developing cell and gene therapies, biologics, vaccines, and cellular agriculture products, operating as a subsidiary of Masco Group.
- Company typePrivate
- Founded2014
- HeadquartersMechelen, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
What VILS does
VILS is a Belgium-headquartered (Niel, registered VAT BE 0554.981.540) design-build engineering firm that delivers manufacturing facility solutions for life science companies operating in advanced therapy medicinal products (ATMPs), biologicals and vaccines, and novel foods. The firm serves customers developing cell therapies, gene therapies, tissue-engineered products, monoclonal antibodies, vaccines, plasma-derived therapies, and cellular agriculture / food ingredient products, addressing the structural problem of translating laboratory-scale discoveries into GMP-compliant manufacturing capacity. VILS positions itself as process-driven rather than facility-driven, with a proprietary IDEA-to-ENGINEERING pathway that progresses an initial idea through concept and business case stages into precise engineering output.
The firm's service offering is a single integrated engagement model combining process architecture, clean utilities design, and full-scope multi-discipline engineering (civil, structural, architectural, HVAC, electrical) with project management. Revenue is generated through professional services / design-build project engagements, priced on a custom per-project basis with no publicly disclosed pricing. The go-to-market is enterprise field sales, supplemented by corporate website, LinkedIn presence, and case stories / client references targeting CTO, VP Manufacturing, and facility director buyers within biopharma and food-tech companies.
VILS operates as a subsidiary of Masco Group, an international conglomerate of specialized life-science engineering brands (Stilmas, Olsa, BCD, Keyplants, DOC, MGA, Techniserv) with 50+ years of design-build-install-service experience. The company is privately held, was founded in 2014, employs between 11 and 50 people, and discloses no venture funding, IPO activity, or standalone financial statements in the available source material.
VILS firmographics
Firmographics- Name
- VILS
- Legal name
- Vils
- Website
- https://vils.be
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- VILS is a Belgian design-build engineering firm that designs and delivers GMP-compliant manufacturing facilities for life science companies developing cell and gene therapies, biologics, vaccines, and cellular agriculture products, operating as a subsidiary of Masco Group.
- Ownership category
- akta.pro rank
VILS industry classification
Industry- Product category
- Life Science Facility Engineering Services
- NAICS
- Specialized Design Services (5414), Other Specialized Design Services (54149)
- akta.pro primary industry
- Testing, Inspection, Certification & Commissioning (TICx) Technical Services (BPAHAIAL)
Keywords
Where VILS is headquartered
LocationHeadquarters
- HQ city
- Mechelen
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
VILS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Design-Build-Install-Service: VILS generates revenue through design, engineering, and construction of manufacturing facilities for life science companies. The company provides end-to-end services from concept development through to fully operational facility delivery, likely through project-based engagements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
VILS product offering
Product offeringCore offering
VILS is a Belgium-based design-build engineering firm that delivers end-to-end manufacturing facility solutions for life science companies. The firm specializes in process-driven facility design, engineering, and construction for advanced therapy medicinal products (ATMPs), biologicals, vaccines, and novel foods sectors, translating laboratory discoveries into operational manufacturing facilities via a structured IDEA-to-ENGINEERING pathway.
Product overview
VILS is a design-build engineering firm that provides end-to-end manufacturing solutions for life science companies. The company operates as a single integrated offering, combining process architecture, facility design, clean utilities, civil/structural/architectural engineering, HVAC, electrical engineering, and project management services. Their portfolio spans three main service areas: (1) ATMP and Linked Industries covering cell therapy, gene therapy, and tissue engineering; (2) Biologicals and Vaccines covering monoclonal antibodies, vaccines, and human plasma derived therapies; and (3) Novel Foods covering cellular agriculture and food ingredients. The company follows a unique IDEA-to-ENGINEERING pathway, starting from an initial idea, developing a detailed concept, forming a robust business case, and culminating in precise engineering and facility creation.
Differentiator
Problem solved
Functional benefit
Products and services
- ATMP and Linked Industries Facility Design
- Biologicals and Vaccines Facility Design
- Novel Foods Facility Design
Companies that use VILS
Customer profileSegments3 records
Ideal customer profiles3 records
VILS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
VILS partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Masco GroupcoreMasco Group is the parent organization of VILS. The group helps life science companies improve manufacturing processes and overcome industry challenges. VILS operates as part of this international team of specialized companies with over fifty years of design-build-install-service capabilities.
- StilmasminorStilmas is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website. Stilmas operates in the life science manufacturing sector.
- OlsaminorOlsa is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
- BCDminorBCD is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
- KeyplantsminorKeyplants is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
- DOCminorDOC is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
- MGA (Masco Group Automation)minorMGA (Masco Group Automation) is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
- TechniservminorTechniserv is a sister company within Masco Group, appearing as one of the Masco Group brand logos on VILS website.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
VILS competitors and assessment
Company assessmentDirect peers
- CRB Group: US-headquartered engineering, architecture, and construction firm focused exclusively on life sciences (pharma, biotech, cell/gene therapy). Highly comparable to VILS in vertical specialization and integrated design-build service model.
- Keyplants: Sister company within Masco Group offering modular cleanroom and turnkey facility solutions for life sciences. Directly comparable to VILS as both operate under the same parent and serve overlapping life-science facility customers with design-build offerings.
- Exyte: Global high-tech facility design-build firm (formerly M+W Group) with strong life-sciences and semiconductor practice. Directly comparable for large-scale, regulated manufacturing facility builds, especially in biologics and ATMPs.
- IPS (Integrated Project Services): Global EPCM firm specialized in regulated life sciences facilities, including process architecture, cleanroom design, and commissioning. Closely comparable to VILS across the full ATMP/biologics value chain.
- Pharmaplan (Tetra Tech): European engineering consultancy specialized in pharmaceutical and biotech facility design. Headquartered in Germany with strong EU footprint overlapping VILS' Belgian base; comparable offering across process engineering and facility design.
- PM Group: Ireland-based international engineering, architecture, and project management firm specializing in advanced manufacturing facilities for pharma, medtech, and food. Directly comparable in design-build scope and European life-sciences client base.
Broad incumbents
- Fluor Corporation: Global EPC major with a life-sciences and advanced manufacturing business unit. Competes for large-scale regulated facility builds; broader portfolio but overlapping client base in pharma manufacturing.
- GEA Group: Major process engineering and equipment supplier for pharma, food, and novel foods industries. Comparable in novel foods and biologics process design, though GEA's core is equipment supply rather than full facility design-build.
- Jacobs Solutions: Large global professional services and engineering firm with a life-sciences practice serving pharma and biotech clients. Broader incumbent versus VILS' ATMP/biologics specialization, but competes for the same enterprise facility-build budgets.
Regional players
- Wunderlich-Malec Engineering: US-based engineering firm with a life-sciences practice serving biotech and pharma manufacturers. Comparable in process and facility engineering scope though regionally concentrated in North America versus VILS' European base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
VILS social profiles
Digital presenceVILS financial estimates
Financial estimateRevenue estimate
Valuation estimate
VILS leadership team
Management profileNumber of profiles
VILS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VILS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VILS
What does VILS do?
VILS is a Belgium-based design-build engineering firm that delivers end-to-end manufacturing facility solutions for life science companies. The firm specializes in process-driven facility design, engineering, and construction for advanced therapy medicinal products (ATMPs), biologicals, vaccines, and novel foods sectors, translating laboratory discoveries into operational manufacturing facilities via a structured IDEA-to-ENGINEERING pathway.
Is VILS a public or private company?
VILS is a private company. It is classified as corporate owned and is currently operating.
When was VILS founded?
VILS was founded in 2014. It employs 11 to 50 people.
Where is VILS based?
VILS is headquartered in Mechelen, Belgium, in the Europe region.
How does VILS make money?
One revenue line is on record: design-Build-Install-Service.
Who are VILS's main competitors?
Direct peers on record are CRB Group, Keyplants, Exyte, IPS (Integrated Project Services), Pharmaplan (Tetra Tech) and PM Group. Broad incumbents are Fluor Corporation, GEA Group and Jacobs Solutions. Wunderlich-Malec Engineering is listed as a regional player.
Does VILS have an API?
No public API is recorded for VILS.
What industry is VILS in?
VILS's product category is Life Science Facility Engineering Services. Its primary akta.pro industry code is BPAHAIAL, Testing, Inspection, Certification & Commissioning (TICx) Technical Services. Its NAICS code is 5414.